Phase 2 Clinical Trial On Inosine Funded By Michael J. Fox Foundation Award Of $5.6M
Apr 17th 2008Drug InformationParkinson's Disease
The Michael J. Fox Foundation announced a $5.6-million award to drive a Phase 2 clinical trial to investigate the potential of inosine - a naturally occurring chemical that gives rise to urate in the body - to slow or stop the progression of Parkinson’s disease.The work is being funded under the Foundation’s LEAPS (Linked Efforts to Accelerate Parkinson’s Solutions) 2007 initiative. LEAPS 2007 was funded with a lead gift from the Edmond J.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
